Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

0(0%)

Results Posted

67%(2 trials)

Terminated

1(25%)

Phase Distribution

Ph phase_1

25%

Ph phase_4

25%

Ph phase_2

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 1Safety & dosage

1(33.3%)

Phase 2Efficacy & side effects

1(33.3%)

Phase 4Post-market surveillance

1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Detailed Status

Completed3

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (33.3%)

Phase 21 (33.3%)

Phase 41 (33.3%)

Trials by Status

completed375%

terminated125%

Recent Activity

0 active trials

Showing 4 of 4

terminatedphase_1

Drug-Drug Interaction and Safety of AZD4041 Study (Part 1) and Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AZD4041 Study in Opioid Use Disorder (Part 2).

NCT06406400

completedphase_4

Buprenorphine Loading in the Emergency Department

NCT04283500

completedphase_2

Maternal Buprenorphine-naloxone Treatment and the Infant

NCT03291847

completed

A Single-Dose Study of an Investigational Capsule Formulation of 2 mg/0.5 mg Buprenorphine/Naloxone

NCT00880841

Clinical Trials (4)

Showing 4 of 4 trials

NCT06406400Phase 1

Drug-Drug Interaction and Safety of AZD4041 Study (Part 1) and Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AZD4041 Study in Opioid Use Disorder (Part 2).

Terminated

NCT04283500Phase 4

Buprenorphine Loading in the Emergency Department

Completed

NCT03291847Phase 2

Maternal Buprenorphine-naloxone Treatment and the Infant

Completed

NCT00880841

A Single-Dose Study of an Investigational Capsule Formulation of 2 mg/0.5 mg Buprenorphine/Naloxone

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4